HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation
- 26 September 2003
- journal article
- Published by Wiley in Transfusion
- Vol. 43 (10) , 1428-1432
Abstract
BACKGROUND: The main objective of the imple‐mentation of NAT for the screening of blood‐borne viruses was to compensate for the failure of serologic assays during the window period. Because this new screening procedure theoretically covers the entire period of infectivity, the necessity for maintaining serologic assays in blood screening strategy could become questionable.STUDY DESIGN AND METHODS: To investigate this issue, a panel of 35 samples has been studied by NAT. These samples had been collected from HIV‐1 antibody‐positive individuals presenting a persistently low viral RNA load (RESULTS: The minipool NAT failed to detect the presence of HIV RNA in 15 of the 35 samples (11 remained negative when retested). Single‐donation testing gave negative results in 4 samples (3 remained negative when retested). Fourteen of the 18 samples with a viral load greater than 50 copies per mL were positive by minipool NAT versus 6 of the 17 samples with fewer than 50 copies per mL (p = 0.02).CONCLUSION: The results clearly demonstrate that anti‐HIV screening should not be withdrawn from biologic qualification procedures of blood donations, even when single NAT is performed.Keywords
This publication has 23 references indexed in Scilit:
- International application of the Incidence Rate/Window Period modelTransfusion, 2002
- Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor populationTransfusion, 2002
- Residual risk of transfusion‐transmitted HCV and HIV infections by antibody‐screened blood in ItalyTransfusion, 2002
- Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000Transfusion, 2002
- Estimated risk of transfusion-transmitted viral infections in SpainTransfusion, 2002
- Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central EuropeTransfusion, 2002
- International Forum: 15Vox Sanguinis, 2002
- Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual MenThe Journal of Infectious Diseases, 2000
- Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseasesTransfusion, 2000
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996